ストックスクリーナーアプリを入手
3.71
5.85%
0.205
アフターアワーズ：
3.34
-0.37
-9.97%
前日終値:
$3.505
開ける：
$3.48
24時間の取引高:
638.29K
Relative Volume:
0.16
時価総額：
$83.29M
収益：
$32.77M
当期純損益:
$-101.98M
株価収益率:
-0.3861
EPS:
-9.6101
ネットキャッシュフロー:
$-112.43M
1週間 パフォーマンス:
-8.17%
1か月 パフォーマンス:
+7.85%
6か月 パフォーマンス:
+14.51%
1年 パフォーマンス:
-79.95%
1日の値動き範囲:
$3.26
$3.76
1週間の範囲:
$3.26
$4.15
52週間の値動き範囲:
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
名前
X 4 Pharmaceuticals Inc
セクター
電話
857-529-8300
住所
61 NORTH BEACON STREET, BOSTON, MA
XFOR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
3.71 | 306.47M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-12 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 再開されました | B. Riley Securities | Buy |
| 2022-12-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 開始されました | Piper Sandler | Overweight |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | ROTH Capital | Buy |
| 2019-12-09 | アップグレード | Citigroup | Neutral → Buy |
| 2019-12-05 | 開始されました | B. Riley FBR | Buy |
| 2019-06-07 | 開始されました | Stifel | Buy |
| 2019-06-05 | 開始されました | Cowen | Outperform |
すべてを表示
X 4 Pharmaceuticals Inc (XFOR) 最新ニュース
Using economic indicators to assess X4 Pharmaceuticals Inc. potentialPortfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
How strong is X4 Pharmaceuticals Inc. stock revenue growthInsider Selling & Daily Market Momentum Tracking - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from AI adoptionMarket Sentiment Summary & Proven Capital Preservation Methods - newser.com
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in X4 Pharmaceuticals Inc - GuruFocus
What moving averages say about X4 Pharmaceuticals Inc.2025 Buyback Activity & Daily Growth Stock Tips - newser.com
Is X4 Pharmaceuticals Inc. (48Q0) stock a fit for income portfoliosTrade Ideas & Risk Managed Investment Entry Signals - newser.com
What candlestick patterns are forming on X4 Pharmaceuticals Inc.Portfolio Profit Report & Weekly Stock Performance Updates - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from commodity pricesEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
X4 Pharmaceuticals: Q3 Earnings Snapshot - CT Insider
How to build a dashboard for X4 Pharmaceuticals Inc. stockInflation Watch & Weekly Stock Performance Updates - newser.com
Why X4 Pharmaceuticals Inc. stock could benefit from AI revolutionStock Surge & Long-Term Safe Investment Plans - newser.com
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference - MarketScreener
XFORX4 Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan
X4 Pharmaceuticals Cuts Losses And Wins Wall Street’s Praise - Finimize
Wall Street analysts’ outlook for X4 Pharmaceuticals Inc (XFOR) - setenews.com
X4 Pharmaceuticals, Inc SEC 10-Q Report - TradingView
X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
X4 Pharma Q3 net loss narrows to $29.8 mln - MarketScreener
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance
How dovish Fed policy supports X4 Pharmaceuticals Inc. (48Q0) stock2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Fierce Biotech Layoff Tracker 2025: Arena BioWorks dissolves; TScan trims team - Fierce Biotech
Top chart patterns to watch in X4 Pharmaceuticals Inc.Portfolio Return Report & Precise Trade Entry Recommendations - newser.com
Layoff Tracker: TScan Cuts 30% to Save $45M, Vaccine Biotech Trims 76 Staffers - BioSpace
Combining machine learning predictions for X4 Pharmaceuticals Inc.Quarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Will X4 Pharmaceuticals Inc. stock recover after recent dropPrice Action & Advanced Swing Trade Entry Plans - newser.com
What recovery options are there for X4 Pharmaceuticals Inc.Quarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Can volume confirm reversal in X4 Pharmaceuticals Inc.Trade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
X 4 Pharmaceuticals Inc (XFOR) 財務データ
収益
当期純利益
現金流量
EPS
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):